ATE557277T1 - Verfahren zur diagnose von endometriose mittels tfpi-2 protein - Google Patents

Verfahren zur diagnose von endometriose mittels tfpi-2 protein

Info

Publication number
ATE557277T1
ATE557277T1 AT04773337T AT04773337T ATE557277T1 AT E557277 T1 ATE557277 T1 AT E557277T1 AT 04773337 T AT04773337 T AT 04773337T AT 04773337 T AT04773337 T AT 04773337T AT E557277 T1 ATE557277 T1 AT E557277T1
Authority
AT
Austria
Prior art keywords
endometriosis
protein
tfpi
diagnosis
methods
Prior art date
Application number
AT04773337T
Other languages
English (en)
Inventor
Yusuke Nakamura
Toyomasa Katagiri
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Application granted granted Critical
Publication of ATE557277T1 publication Critical patent/ATE557277T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/364Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT04773337T 2003-09-24 2004-09-14 Verfahren zur diagnose von endometriose mittels tfpi-2 protein ATE557277T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50557203P 2003-09-24 2003-09-24
PCT/JP2004/013718 WO2005029089A2 (en) 2003-09-24 2004-09-14 Method of diagnosing ovarian endometriosis using tfpi-2 protein

Publications (1)

Publication Number Publication Date
ATE557277T1 true ATE557277T1 (de) 2012-05-15

Family

ID=34375581

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04773337T ATE557277T1 (de) 2003-09-24 2004-09-14 Verfahren zur diagnose von endometriose mittels tfpi-2 protein

Country Status (4)

Country Link
EP (1) EP1668371B1 (de)
JP (1) JP4603548B2 (de)
AT (1) ATE557277T1 (de)
WO (1) WO2005029089A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2379096T (lt) 2008-12-19 2019-12-27 Baxalta GmbH Tfpi inhibitoriai ir vartojimo būdai
US8962563B2 (en) 2009-12-21 2015-02-24 Baxter International, Inc. TFPI inhibitors and methods of use
KR20110137337A (ko) 2009-03-06 2011-12-22 모찌다 세이야쿠 가부시끼가이샤 자궁 내막증의 판정 방법 및 자궁 내막증의 진단용 키트
EP2547355B1 (de) 2010-03-19 2017-01-11 Baxalta GmbH Tfpi-hemmer und verwendungsverfahren dafür
JP6074676B2 (ja) * 2011-08-19 2017-02-08 公立大学法人横浜市立大学 組織因子経路阻害因子2(tfpi2)測定による卵巣明細胞腺癌の検査方法および検査薬
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
US20170322218A1 (en) 2014-11-27 2017-11-09 Public University Corporation Yokohama City University Method and reagent for detecting ovarian clear cell adenocarcinoma
CA3172404A1 (en) * 2020-02-26 2021-09-02 Public University Corporation Yokohama City University Method and reagent for detecting malignant ovarian tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60321356D1 (de) * 2002-08-30 2008-07-10 Oncotherapy Science Inc Verfahren zur diagnostik von eierstock endometriose

Also Published As

Publication number Publication date
JP2007506965A (ja) 2007-03-22
EP1668371B1 (de) 2012-05-09
EP1668371A2 (de) 2006-06-14
WO2005029089A9 (en) 2006-05-04
WO2005029089A3 (en) 2005-06-02
JP4603548B2 (ja) 2010-12-22
WO2005029089A2 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
DE602004026014D1 (de) Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE60233949D1 (de) Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
ATE312351T1 (de) Verfahren zur bestimmung der bildung von endothelinen zu zwecken der medizinischen diagnostik, sowie antikörper und kits für die durchführung eines solchen verfahrens
RU2015116674A (ru) Способ диагностики или мониторинга почечной функции или диагностики почечной дисфункции
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
ATE473448T1 (de) Verfahren zur diagnose von herz-kreislauf- krankheiten
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
ATE354095T1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
ATE406579T1 (de) Verfahren zur diagnose von tumoren
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
WO2022241292A3 (en) Use of markers in the diagnosis and treatment of parkinson's disease
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
ATE476665T1 (de) Natriurethische peptide und plazenta- wachstumfaktor/löslicher vegf-rezeptor unterscheiden zwischen mit der plazenta verbundener herzdysfunktion und mit herzerkrankung verbundener herzdysfunktion
WO2019053117A8 (en) Pct and pro-adm as markers for monitoring antibiotic treatment
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
NZ590993A (en) Dual specificity phosphatase 1 protein (DUSP1) for diagnosis and prognosis of skin cancer